
ORI
Old Republic International Corporation
Company Overview
| Mkt Cap | $9.90B | Price | $46.21 |
| Volume | 1.03M | Change | +2.51% |
| P/E Ratio | 11.6 | Open | $45.50 |
| Revenue | $8.2B | Prev Close | $45.08 |
| Net Income | $852.7M | 52W Range | $33.00 - $44.76 |
| Div Yield | 1.16% | Target | $46.50 |
| Overall | 95 | Value | 100 |
| Quality | -- | Technical | 91 |
No chart data available
About Old Republic International Corporation
Old Republic International Corporation, through its subsidiaries, provides insurance underwriting and related services primarily in the United States and Canada. The company operates in two segments, Specialty Insurance and Title Insurance. The Specialty Insurance segment offers accident and health, aviation, commercial auto, commercial multi-peril, commercial property, excess and surplus, general liability, home and auto warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, directors and officers, and surety. This segment provides its insurance products to businesses, state and local governments, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. Old Republic International Corporation was founded in 1923 and is based in Chicago, Illinois.
Latest News
Orica Limited Announces Director’s Acquisition of Shares
Oric Pharmaceuticals’ 2025 Restructuring: Potential Risks and Financial Implications
J.P. Morgan Sticks to Its Buy Rating for Orica Limited (OCLDF)
Wedbush Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)
Morgans Remains a Buy on Orica Limited (OCLDF)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORI | $46.21 | +2.5% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Old Republic International Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW